000 00939 a2200301 4500
005 20250512010201.0
264 0 _c19850705
008 198507s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(85)92408-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGlasky, A J
245 0 0 _aInosine pranobex.
_h[electronic resource]
260 _bLancet (London, England)
_cMay 1985
300 _a1103-4 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aFemale
650 0 4 _aHerpes Genitalis
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInosine
_xanalogs & derivatives
650 0 4 _aInosine Pranobex
_xtherapeutic use
650 0 4 _aMale
700 1 _aGalli, M
700 1 _aLassus, A
700 1 _aSalo, O
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8437
_gp. 1103-4
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(85)92408-0
_zAvailable from publisher's website
999 _c2588116
_d2588116